Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
Authors:
- 1 March 2010
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 33 (3) , 140-152
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunityProceedings of the National Academy of Sciences, 2009
- Role of the renin-angiotensin system in autoimmune inflammation of the central nervous systemProceedings of the National Academy of Sciences, 2009
- p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturationProceedings of the National Academy of Sciences, 2009
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animalsProceedings of the National Academy of Sciences, 2009
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- The Cellular Context of T Cell SignalingImmunity, 2009
- Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog‐gli1 in autoimmune encephalomyelitis and multiple sclerosisAnnals of Neurology, 2008
- Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiencyNature Neuroscience, 2008
- Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitorsProceedings of the National Academy of Sciences, 2007
- Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisProceedings of the National Academy of Sciences, 2006